Veristat: Advancing Revolutionary Therapies (ART): Orphan Drug Designations and Orphan Subsets

Citeline Podcasts

English - April 05, 2023 13:20 - 9 minutes - 12.6 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 글로벌 빅파마와의 접촉은 빠를수록 좋다 (Korean-language podcast)

Next Episode: A Man On Fire Fueled By A Mission To Find A Drug For Every Disease.

Find out more now about US FDA’s Orphan Drug Designation (ODD) program, which qualifies sponsors for incentives including tax credits, exemption from user fees, and more. Learn more about which orphan subsets could qualify for ODD, in your free podcast episode